Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
All edits
Edits on 10 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+288 characters)
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
Article
Study summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetcs and pharmacodynamics of single- and multiple doses of ARO-ANG3 in healthy adult volunteers and in dyslipidemic patients including familial hypercholesterolemia and severe hypertriglyceridemia.
Infobox
Is a
NCT Number
Trial Recruitment Size
930
Trial Sponsor
Clinical Trial Start Date
January 7, 2019
0Primary Completion Date
May 17, 2021
0Study Completion Date
May 17, 2021
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Official Website
Official Name
A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients0
Last Updated
September 21, 2021
0Allocation Type
Randomized0
Intervention Model
Sequential Assignment0
Masking Type
Quadruple0
Find more entities like Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.